PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
10.46
-0.50 (-4.56%)
At close: Feb 11, 2026, 4:00 PM EST
10.20
-0.26 (-2.49%)
After-hours: Feb 11, 2026, 7:59 PM EST

PAVmed Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
3.139.79-64.18-88.98-50.35-34.28
Depreciation & Amortization
0.161.22.932.460.230.02
Loss (Gain) From Sale of Assets
--72.29-1---
Asset Writedown & Restructuring Costs
----0.13-
Loss (Gain) From Sale of Investments
-6.1-0.53----
Stock-Based Compensation
2.517.0511.7619.5315.012.04
Other Operating Activities
-4.22-9.28-3.15-3.28-4.0510.21
Change in Accounts Receivable
0.010.04-0.040.18-0.2-
Change in Accounts Payable
-0.13-0.06-0.92-0.740.170.5
Change in Other Net Operating Assets
1.110.532.55-0.16-1.54-0.42
Operating Cash Flow
-3.56-33.55-52.04-70.99-40.59-21.91
Capital Expenditures
-0.02-0.06-0.24-1.54-1.47-0.06
Sale of Property, Plant & Equipment
--1---
Divestitures
--16.48----
Sale (Purchase) of Intangibles
-0.35--3.2-2.25-
Investing Cash Flow
-0.02-16.180.76-4.74-3.72-0.06
Short-Term Debt Issued
-----3.7
Long-Term Debt Issued
--1035.23-13.6
Total Debt Issued
--1035.23-17.3
Long-Term Debt Repaid
--0.53-0.08--14.97-0.6
Net Debt Issued (Repaid)
--0.539.9235.23-14.9716.7
Issuance of Common Stock
3.541.661.790.74126.2616.4
Repurchase of Common Stock
----0.37--
Other Financing Activities
2.3830.1619.462.61-6.98-0.1
Financing Cash Flow
5.9231.2831.1738.21104.3133.01
Net Cash Flow
2.34-18.45-20.11-37.516011.04
Free Cash Flow
-3.58-33.61-52.28-72.53-42.06-21.97
Free Cash Flow Margin
-12351.72%-1122.17%-2132.06%-19237.40%-8412.00%-
Free Cash Flow Per Share
-6.67-15.44-216.88-366.39-244.17-208.43
Levered Free Cash Flow
-11.93-20.32-27.92-39.42-22.18-12.19
Unlevered Free Cash Flow
-11.92-20.29-27.55-38.62-22.18-12.16
Change in Working Capital
10.511.59-0.72-1.570.08
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q